There definitely exists a seemingly huge chasm between the antibiotic 
stewardship camp and the "better cover it all" camp.


Unlike the scenario that you described, most patients will not arrive at our 
door step with cultures that have demonstrated an organism - in fact bugs 
circulating systemically are only "caught" and grown 40-60% of the time that 
they are present by some estimates.
I don't know the statistics on what % of patients actually have more than 1 
colonization/infection (multiple bugs) however.

Second, if we are considering an inpatient, who is already on an anti-infective 
directed toward a specific organism, and the patient is worsening, it makes 
sense to consider broader coverage.

I am not suggesting that I have the answer - antibiotic stewardship has 2 
components however:

1.     Reduction of the creation of resistant organisms - 1 dose of a BS 
antibiotic will not likely cause this

2.     Reduction of cost - but calculate the cost of a sicker patient that has 
a longer LOS and possibly an ICU stay tacked on vs. the cost of a few doses of 
Zosyn.

I think that this discussion is not over by any means, it is happening at the 
CMS level right now.

The take home message is clear however; we have had statistically significant 
reduction of mortality from severe sepsis and septic shock over the history of 
the Surviving Sepsis Campaign as a result of the guidelines and recommendations 
created.  I also know that an effective antibiotic is better than some random 
BS antibiotic. But the BS coverage is recommended in the first 3 hours of 
presentation of severe sepsis - until the organism can be identified or 
surmised.
I guess I always resort to what I would choose for myself or loved one -

This has been more of an editorial than an answer - but I have been thinking 
about this for quite some time.

Let's just DO BOTH. Give the directed agent if you think that you know the 
organism, cover the patient with BS empirically per the guidelines and then use 
good antibiotic stewardship to de-escalate as soon as possible while still 
providing source control in the best possible way.

Thanks,

MARY ANN BARNES-DALY RN BSN CCRN DC  | Clinical Performance Improvement 
Consultant
Sutter Health - Office of Patient Experience | 2200 River Plaza Drive, 
Sacramento, CA 95833
Mobile 916.200.5604| Office 916.286.6717  | [email protected]

"You never change things by fighting the existing reality. To change something, 
build a new model that makes the existing model obsolete."         ~R. 
Buckminster Fuller

From: Sepsisgroups [mailto:[email protected]] On 
Behalf Of Gluckner, Rhonda
Sent: Tuesday, October 20, 2015 6:00 AM
To: [email protected]
Subject: [Sepsis Groups] anbitiotic choice

I have a question posed to me about antibiotic choices by one of our 
physicians. I apologize if this has already been asked, but there is so much 
confusion around certain aspects of this new metric.

This scenario was presented to me:
A patient arrives at the hospital (whether direct admit or through the ED) for 
admission to the hospital for positive blood cultures (previously drawn and 
results called to PCP) and the organism has been identified with sensitivities 
completed. If the sensitivities indicate an effective antibiotic that is not 
listed on the monotherapy, do we still have to administer the second antibiotic 
to fall in line with the metric despite what would obviously be over-use of an 
antibiotic and poor stewardship?

I understand this scenario is probably not very realistic as one of the 
monotherapy antibiotics is probably going to be listed as an effective 
antibiotic on the sensitivities, but I was asked to pose this question to the 
group.

Thanks everyone for you input!

Rhonda Gluckner, BSN, RN
Sepsis Coordinator, Mercy Health-Youngstown
Co-Chair, Mercy Health Sepsis Management Advisory Team
Office:  330.480.2935
Pager:  330.229.2035
Fax:  330.480.3177
[email protected]<mailto:[email protected]>


CONFIDENTIALITY NOTICE: This message, including any attachments, is for the 
sole use of the intended recipient(s) and may contain confidential and 
privileged information. Any unauthorized review, use, disclosure or 
distribution is prohibited. If you are not the intended recipient, please 
contact the sender by reply e-mail and destroy all copies of the original 
message.
_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

Reply via email to